CLINICAL_TRIALS
trial_result
· 2018-06-25
Clinical Trial Update: Bevacizumab in Treating Patients With Angiosarcoma [Phase 2]
Summary
Phase 2 trial evaluating bevacizumab for angiosarcoma has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northwestern University | Conditions: Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2018-06-25